Active surveillance is most appropriate for you medically if: You aren’t experiencing any symptoms You have a slow-growing cancer (Gleason score of less than 6) Your cancer is small (cannot …

Jan 16, 2024 · Summary: This is a partially blinded randomized controlled phase II pilot study comparing Poly-ICLC (Hiltonol®) treatment vs no treatment, for prostate cancer participants …

When Bill was first informed of his advanced disease (Gleason Total Score 9, Grade T-3A) in 1995, the recommendation to go on hormone therapy with Lupron. In addition, Bill made …

High-Intensity Focused Ultrasound or HIFU is a non-invasive heating procedure for treating localized prostate cancer.

Mount Sinai Health System offers patients the full range of clinical care specialties and treatments, as well as a vast network of facilities.

If you have cancer that is clinically insignifi cant (Gleason 6), we would recommend active surveillance. However, if there is clinically signifi cant cancer (any Gleason 7, more than 2 …

Oct 2, 2018 · A pathology test that applies artificial intelligence (AI) to characterize tissue samples can accurately predict clinically significant prostate cancer disease progression following …

Dec 1, 2025 · - With a Gleason score of ≤6, treated within the last 24 months, or untreated and under surveillance - With a Gleason score of 3+4 that has been treated >6 months prior to full …

We use the Gleason Score grading system to determine appropriate treatment options based on how aggressive your cancer is. The higher the score, the more quickly the cancer will grow. …

Jul 27, 2023 · Participants with low-risk prostate cancer (i.e., Gleason score < 7 and prostate specific antigen < 10 ng/mL) are allowed. - Pregnancy or breastfeeding or intent to become …